Immunologic Techniques
- Name
- Immunologic Techniques
- Accession Number
- DBCAT005078
- Description
Techniques used to demonstrate or measure an immune response, and to identify or measure antigens using antibodies.
- Drugs
Drug Drug Description Brexucabtagene autoleucel A modified autologous chimeric antigen receptor (CAR) T cell therapy employing a modified murine anti-CD19 single-chain variable fragment linked to CD28 and CD3ΞΆ co-stimulatory domains for the treatment of patients with relapsed and refractory mantle cell lymphoma. - Drugs & Drug Targets
Drug Target Type Brexucabtagene autoleucel B-lymphocyte antigen CD19 target